Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.
about
Phospho-aspirin-2 (MDC-22) inhibits estrogen receptor positive breast cancer growth both in vitro and in vivo by a redox-dependent effectPhospho-NSAIDs have enhanced efficacy in mice lacking plasma carboxylesterase: implications for their clinical pharmacology.Curcumin enhances the lung cancer chemopreventive efficacy of phospho-sulindac by improving its pharmacokinetics.
P2860
Phospho-sulindac (OXT-328) inhibits the growth of human lung cancer xenografts in mice: enhanced efficacy and mitochondria targeting by its formulation in solid lipid nanoparticles.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@ast
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@en
type
label
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@ast
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@en
prefLabel
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@ast
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@en
P2093
P2860
P1476
Phospho-sulindac (OXT-328) inh ...... in solid lipid nanoparticles.
@en
P2093
Basil Rigas
Gerardo Mackenzie
Ka-Wing Cheng
Kveta Vrankova
Liqun Huang
Panayiotis P Constantinides
Rongrong Zhu
P2860
P304
P356
10.1007/S11095-012-0801-X
P577
2012-06-22T00:00:00Z